1. Jensen OM, Parkin DM, MacLennan R, et al., eds. Cancer Registration: Principles and Methods. IARC Scientific Publication No. 95. Lyon, France: International Agency for Research on Cancer; 1991.
2. Hoffman FL. Discussion to the paper of FC Wood. Am J Public Health. 1930;20:19-20.
3. Griswold MH, Wilder CS, Cutler SJ, Pollack ES. Cancer in Connecticut 1935-51. Hartford, CT: Connecticut State Department of Health: 1955.
5. Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. Acta Pathol Microbiol Scand. 1965;4(suppl 174).
6. Stocks P. Cancer registration and studies of incidence by surveys. Bull World Health Organ.
7. Clemmesen J. Symposium on the Geographic Pathology and Demography of Cancer. Paris: Council for the Coordination of International Congresses of Medical Statistics: 1951.
8. Union Internationale Contre le Cancer. Cancer Incidence in Five Continents, Vol. 1. Doll R, Payne P, Waterhouse JAH, eds. Geneva, Switzerland: Union Internationale Contre le Cancer: 1966.
9. Parkin D. The evolution of the population-based cancer registry. Nat Rev Cancer. 2005;6(8):603-612.
11. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev.
14. Gloeckler Ries LA, Reichman ME, Lewis DR, et al. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003;8(6):541-552.
16. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer.
17. Baquet CR, Mishra SI, Commiskey P, et al. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc.
18. Hausauer AK, Keegan TH, Chang ET, Clark CA. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res. 2007;9(6):R90.
19. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol.
20. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007;9(3):R28.
21. Gnerlich J, Jeffe DB, Deshpande AD, Beers C. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol.
25. Nattinger AB, McAuliffe TL, Shapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol.
26. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-3-18.
27. Freeman JL, Klabunde CN, Schussler N, et al. Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Med Care. 2002;40(8 suppl):IV-36-42.
28. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between black and white women. Ann Intern Med.
29. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8 suppl):IV-43-48.
30. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(8 suppl):IV-55-61.
31. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol.
32. Gross CP, Smith BD, Wolf E, Anderson M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer.
33. Hershman DL, Buono D, McBride RB, et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst.
34. Baldwin LM, Adamache W, Klabunde CN, et al. Linking physician characteristics and Medicare claims data: issues in data availability, quality and measurement. Med Care. 2002;40(8 suppl):IV-82-95.
35. Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst.
36. Field TS, Doubeni C, Fox MP, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med.
37. Stokes ME, Thompson D, Montoya EL, et al. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-Medicare data. Value Health.
38. Earle CC, Nattinger AB, Potosky AL, et al. Identifying cancer relapse using SEER-Medicare data. Med Care. 2002;40(8 suppl):IV-75-81.
39. Lackan NA, Ostir GV, Freeman JL, et al. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung and prostate cancer. Med Care.
40. Lackan NA, Freeman JL, Goodwin JS. Hospice use by older women dying with breast cancer between 1991-1996. J Palliat Care.
41. Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in HMO and fee-for-service settings. J Natl Cancer Inst.
42. Riley GF, Potosky AL, Klabunde CN, et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA.
43. Greenberg CC, Schneider EC, Lipsitz SR, et al Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction? J Am Coll Surg.
44. Edge SB, Gold K, Berg CD, et al. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer.
45. Thwin SS, Fink AK, Lash TL, Silliman RA. Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologists. Cancer.
46. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med.
50. Centers for Disease Control and Prevention. State cancer registries: status of authorizing legislation and enabling regulations—United States, October 1993. Morb Mortal Wkly Rep. 1994;43(4):71, 74-75.
51. Weir HK, Berg GD, Manley EC, Belloni KA. The National Program of Cancer Registries: explaining state variations in average cost per case reported. Prev Chronic Dis. 2005;2(3):1-10.
52. Wingo PA, Jamison PM, Hiatt RA, et al. Building the infrastructure for nationwide cancer surveillance and control—a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) program (United States). Cancer Causes Control.
54. US Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: 2007.
57. National Program of Cancer Registries, Literature Review of Data from Statewide Cancer Registries in the U.S. Available at: http://www.cdc.gov/cancer/npcr/
. Accessed July 12, 2008.
58. Saltzstein, SL. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry. Anat Pathol. 1996;1:193-203.
59. Kern KA, Flannery JT, Kuehn PG. Carcinogenic potential of silicone breast implants: a Connecticut statewide study. Plast Reconstr Surg. 1997;100(3):737-747; discussion 748-749.
60. Maskarinec G, Wilkens L, Meng L. Mammography screening and the increase in breast cancer incidence in Hawaii. Cancer Epidemiol Biomarkers Prev.
61. Howe HL, Katterhagen JG, Yates J, Lehnherr M. Urban-rural differences in the management of breast cancer. Cancer Causes Control.
62. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med.
63. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol.
66. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol.
69. Reid-Lombardo KM, Gay G, Patel-Parekh L, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from the National Cancer Data Base. J Gastrointest Surg. 2007;11:410-9; discussion 419-420.
70. National Cancer Database, National Quality Forum Endorsed Commission on Cancer Measures for Quality of Cancer Care for Breast and Colorectal Cancers. Available at: http://www.facs.org/cancer/qualitymeasures.html
. Accessed July 12, 2008.
72. Kennedy T, Stewart AK, Bilimoria KY, et al. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Ann Surg Oncol.
73. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg.
74. Foulkes WD, Wong N, Brunet JS, et al. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res.
75. Rosen PP, Lesser ML, Arroyo CD, et al. Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis. Cancer.
76. Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Ann Surg Oncol.
77. NCCN: NCCN Clinical Practice Guidelines in Oncology
. 1st ed. Jenkintown, PA: The National Comprehensive Cancer Network: 2006. Available at: www.nccn.org
. Accessed August 2, 2008.
78. Weeks J, Niland J, Hughes ME, et al. Institutional Variation in Concordance with Guidelines for Breast Cancer Care in the National Comprehensive Cancer Network: Implications for Choice of Quality Indicators. Seattle, WA: Academy Health Annual Research Meeting: 2006.
79. Hassett MJ, Hughes ME, Niland JC. Selecting high priority quality measures for breast cancer quality improvement. Med Care.
81. National Cancer Institute, Geographic Information Systems. Available at: http://gis.cancer.gov
. Accessed August 2, 2008.
84. Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or necessity? Lancet Oncol.
85. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin.
86. Pediatric Oncology Networked Database (POND). Available at: www.pond4kids.org
. Accessed July 25, 2008.
87. Ayoub L, Fu L, Pena A, et al. Implementation of a data management program in a pediatric cancer unit in a low income country. Pediatr Blood Cancer.
88. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-income countries. Cancer.
89. Anderson BO, Jakesz R. Breast cancer issues in developing countries: an overview of the breast health global initiative. World J Surg.
91. Guidelines for International Breast Health and Cancer Control-Implementation. Cancer. 2008;113(S8):2215-2371.